MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$67.96
+5.51%
Mkt Cap $3.04B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$71.50
Range $56.00 – $90.00
Implied Upside
+5.2%
Consensus $71.50 vs current $67.96